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Background. Risk factors for mortality in community-residing persons developing congestive heart failure (CHF) and acute myocardial
infarction (AMI) may differ for males and females.
Method. Persons from the Groningen Longitudinal Aging Study with incident CHF (N=274) or AMI (N=198) were identified between 1993
and 1998 and their survival status was collected in 2001. Risk factors are assessed prior to the cardiac diagnosis.
Results. The 1-, 5-, 7-year survival rates were 65, 53, 50% for AMI and 74, 45, 32% for CHF. Multivariate analyses showed that male gender,
high age, smoking, diabetes and low physical function were risk factors for mortality among persons with CHF. For AMI, 1 month mortality was
related to high age and baseline low body mass index, while longer term mortality was related to male gender and high age. In addition, diabetes
increased longer term mortality among females but not among males with AMI. Depression was not a risk factor for mortality for either condition
in either gender.
Conclusion. Males with CHF or AMI have worse survival rates compared to females. Risk factors for mortality are predominantly similar for
males and females, except for diabetes which is a risk factor among females, but not males with AMI.
© 2006 Elsevier Inc. All rights reserved.Keywords: Myocardial infarction; Congestive heart failure; Depression; Aged; Diabetes mellitus; Survival rate; SexIntroduction
Coronary heart diseases (CHD), including acute myocardial
infarction (AMI) and chronic heart failure (CHF), are associated
with increased mortality (Goldberg et al., 1999; Levy et al.,
2002). There are differences in the incidence and clinical
presentations of CHD between males and females (Barrett-
Connor, 1997; Chen et al., 1999; Van Jaarsveld et al., 2002).
Better survival for female compared to male patients is reported
(Kober et al., 1996; Levy et al., 2002). In AMI patients,
contrasting results are found depending on whether short-term⁎ Corresponding author. Fax: +31 50 3632406.
E-mail address: c.jaarsveld@ucl.ac.uk (C.H.M. van Jaarsveld).
0091-7435/$ - see front matter © 2006 Elsevier Inc. All rights reserved.
doi:10.1016/j.ypmed.2006.06.010(within 1 month) or longer term survival is studied. Increased
mortality rates within 1 month after diagnosis is reported in
young but not in older females (>65 years) (Abildstrom et al.,
2003; Chen et al., 1999; Rosengren et al., 2001). Others report
no gender difference (Galatius-Jensen et al., 1996) or increased
short-term mortality among males (MacIntyre et al., 2001).
Although results are contradictory, most studies among older
persons indicate worse survival among males on the long term
(Kober et al., 1996; Vaccarino et al., 2001).
The question remains what causes gender difference in
mortality among CHD patients. One explanation concerns
gender-related differences in the prevalence of risk factors for
overall mortality such as smoking, body mass index and
comorbidity (Yusuf et al., 2004). Second, risk factors may have
differential effects for males and females. A meta-analysis
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for females (Lee et al., 2000), while males show greater effects
of disability, cholesterol and smoking (Janghorbani et al.,
1993; Kattainen et al., 2004; Marang-van de Mheen et al.,
2001).
Classic risk factors for mortality associated with CHD
include gender, age, socio-economic status (Fried et al., 1998),
marital status (Coyne et al., 2001), health status (e.g.,
hypertension and diabetes mellitus (Kannel and McGee,
1979; Sachdev et al., 2004), and potentially modifiable factors
related to behavior (e.g., smoking and body mass index) (Fried
et al., 1998). In addition, low self-rated health has been found
to be a predictor for mortality (Idler and Benyamini, 1997).
Although the mechanisms by which a self-rating of health
predicts future mortality are diverse and largely unknown,
ratings of self-rated health undoubtedly reflect inadequately
measured and unmeasured objective factors, and it is
suggested that the meaning of these self-ratings differ for
males and females (Spiers et al., 2003). Depression has
attracted particular attention because it is highly prevalent, a
robust predictor for mortality in many populations, especially
among AMI patients, and potentially modifiable by treatment
(Barefoot et al., 1996; Frasure-Smith and Lesperance, 2003;
Van Melle et al., 2004).
This study aims at identifying independent risk factors for
mortality among community-residing persons who develop
either CHF or AMI and determines whether effects of risk
factors differ according to gender. Data originate from the
Groningen Longitudinal Aging Study (GLAS) which offers an
unusual opportunity, since it includes up to 8-year follow-up of
persons with incident CHF and AMI. Moreover, data on risk
factors are customarily collected after diagnosis. However, in
the present paper, we present data on pre-morbid assessed risk
factors.
Methods
Groningen longitudinal aging study
Detailed description of data collection is published elsewhere (Kempen et
al., 1997a,b, 1998; Ormel et al., 1997). Briefly, the study population comprised
8723 persons aged 57 and older on January 1st 1993, who were registered as
patients with the 27 general practitioners participating in the Morbidity
Registration Network Groningen. 152 persons died or left the practice by the
time contact was initiated. Useful baseline data were available for 5279 subjects
(62%; 5279/(8723–152)).
Incident CHF or AMI
From 1993 until January 1st, 1998, all patients with a new post-baseline
episode of AMI or diagnosis of CHF according to the criteria of the
International Classification of Primary Care were identified by general
practitioners (Lamberts and Wood, 1987). AMI was diagnosed if two of the
following three symptoms were present: chest pain characteristic of
myocardial ischemia lasting more than 15 min, abnormal ST-T changes or
Q waves on an electrocardiogram, or elevation of blood cardiac enzymes. CHF
was diagnosed if three of the following five symptoms were present:
dependent edema, raised jugular venous pressure or hepatomegaly in the
absence of liver disease, signs of pulmonary congestion or pleural effusion,
enlarged heart, or dyspnoea in the absence of pulmonary disease.During the enrolment period (1993–1998), 198 patients with a new
episode of AMI and 274 patients with a first diagnosis of CHF after baseline
were recruited. Cases with both diagnoses in the enrolment period (N=28)
were included according to the first diagnosis. The study protocol was
approved by the Medical Ethical Committee of the University Medical Centre
Groningen.
Mortality
Survival was ascertained for all patients on June 1st 2001 using municipal
registrations. All-cause mortality was included in this study. For several reasons, it
is more relevant to study all cause mortality in a community-based older population
as ours. Classification of causes of death always involves a subjective component
(Gottlieb, 1997). Moreover, most older persons die as a consequence of a
combination of factors, and the recorded cause of death may be less explanatory in
older than in younger persons (Fried et al., 1998).
Risk factors for mortality
Risk factors are assessed during the baseline assessment in 1993, i.e., prior to
the cardiac diagnosis.
Demographic risk factors include: gender, age, marital status (living with
versus without a partner) and educational level (high versus low).
Baseline health status includes comorbidity, physical functioning, and self-
rated health. Comorbidity is assessed with total number of 19 chronic medical
conditions. In order to reduce report bias, only those conditions in the 12 months
prior to the interview that required a GP or specialist consult and/or prescription
of medicine were counted, which was found to be valid (Kriegsman et al., 1996).
In addition the presence of hypertension and diabetes mellitus are analyzed
separately.
Physical functioning was assessed with the Groningen Activity Restriction
Scale (GARS), comprising 18 ADL (activities of daily living) and IADL
(instrumental activities of daily living) items, each with four response categories.
Scores may range from 18 (no physical dysfunction) to 72 (maximum level of
physical dysfunction). Results of previous studies show that GARS meets the
stochastic cumulative scalability criteria of the Mokken Model (Kempen et al.,
1996; Kempen and Suurmeijer, 1990).
Self-rated health is assessed with a 1-item question: “how do you rate your
overall health” (Miilunpalo et al., 1997). Scores were classified in two categories
due to skewed distribution: 0 (excellent, very good, good), 1 (fair, bad).
Potentially modifiable risk factors include: smoking, Body Mass Index
(BMI) and depression. Smoking behavior was assessed by a self-report
questionnaire and defined in two classes: (0) never smoked cigarettes or
cessation of smoking more than 10 years ago, and (1) current smoker or
cessation of smoking less than 10 years ago. BMI was calculated as weight (kg)
divided by the square of height (m2) (both self-report), and categorized using
cut-offs recommended by the World Health Organization: normal weight (18.5
to <25), overweight (25 to <30) and obese (≥30) (World Health Organization,
1998). Three underweight cases (BMI<18.5) were excluded.
Depressive symptomswere assessed with theHospital Anxiety andDepression
Scale (HADS) (Spinhoven et al., 1997; Zigmond and Snaith, 1983). HADS has
been validated for an older Dutch population (Spinhoven et al., 1997). Due to a
skewed distribution, depression scores were dichotomized using a standardized cut
point: 7 or lower (non-case) and 8 or higher (possible case) (Bjelland et al., 2002;
Spinhoven et al., 1997; Zigmond and Snaith, 1983).
Analyses
Risk factors for mortality are analyzed for CHF using 8 year follow-up. In
AMI patients, predictors for short-term mortality (within 1 month) and longer
term mortality are analyzed separately. First, univariate hazards (odds ratios)
associated with each risk factor were examined. Second, multivariate Cox
proportional hazard analyses were performed with a stepwise forward
conditional method including all potential risk factors. Finally, interaction
(effect modification) between all risk factors and gender was tested with two-
way product terms. Each interaction term (and the single risk factor, if not yet
in the model) was successively added to the multivariate model to evaluate
Table 1
Baseline risk factors (prior to diagnosis) according to diagnosis and gender: the Groningen Longitudinal Aging Study, Groningen, The Netherlands, 1993–2001
Persons with CHF Persons with AMI
Males Females p a Males Females p a
Number of patients (%) 131 (48) 143 (52) 122 (62) 76 (38)
Age in years, mean (SD) 74.3 (7.1) 76.7 (7.7) 0.008 68.9 (7.9) 73.1 (7.6) <0.001
Without partner (%) 21 64 <0.001 16 51 <0.001
Low educational level (%) 52 83 <0.001 49 82 <0.001
Smoking (%) 42 20 <0.001 48 34 0.050
BMI (%)
Normal (18.5–<25) 45 39 39 54
Overweight (25–<30) 49 43 0.011 52 35 0.067
Obese (≥30) 6 18 9 11
Hypertension (%) 22 32 0.058 18 28 0.111
Diabetes (%) 9 18 0.029 10 15 0.322
Number of chronic conditions, mean (SD) 1.6 (1.4) 1.8 (1.5) 0.218 1.1 (1.0) 1.6 (1.4) 0.004
Physical disability, mean (SD) 24.9 (8.0) 30.0 (12.1) <0.001 21.8 (5.6) 25.6 (8.3) 0.001
Depressive symptoms (≥8) (%) 26 37 0.048 17 22 0.370
Low self-rated health (%) 53 57 0.538 34 50 0.026
a P-value of gender difference according to Chi-squared tests for categorical variables and t-tests for continuous variables.
363C.H.M. van Jaarsveld et al. / Preventive Medicine 43 (2006) 361–367possible interaction effects with gender. A p value of <0.05 was considered
statistically significant. Analyses are performed with SPSS for windows
version 12.
Results
Table 1 shows the prevalence of risk factors at baseline
among males and females for both patient groups. Several risk
factors are more pronounced among females, while smoking is
more prevalent among male patients. Survival rates at several
intervals are presented in Table 2.Risk factors for mortality among persons with CHF
Table 3 shows the results of the Cox proportional hazard
analyses among persons with CHF. At a univariate level, higher
age, living without a partner, diabetes mellitus, high physical
disability and low self-rated health are significantly related to
mortality, but gender is not. Because several risk factors are
more pronounced among females, while smoking is more
prevalent among males, gender effects may be magnified or
overlooked in univariate analyses. The multivariate model
reveals five significant risk factors: male gender, higher age,
smoking, diabetes mellitus and physical disability. This multi-
variate model shows that male gender is associated with a 1.7Table 2
Survival rates at time intervals for persons with CHF or AMI: the Groningen Longi
Survival rates at time intervals in percent and [95% CI] a
1 month 6 month 1 year
CHF 90 [87, 93] 83 [79, 87] 74 [69, 79]
AMI 71 [65, 77] 68 [62, 74] 65 [58, 72]
a Follow-up is complete up to 3 years; 5-year follow-up is available for 84% of per
66% of persons with CHF and 59% of persons with AMI.increased mortality risk, after adjusting for the other four
significant risk factors.
None of the two-way interaction terms of risk factors with
gender is significant. However, additional multivariate analyses
(not shown) indicated that smoking tended to be associated with
a 1.9 significant increased risk among males (95% CI: 1.2, 3.0)
but not among females (adjusted OR=1.2, 95% CI: 0.6, 2.2).
Similarly, the multivariate adjusted risk associated with diabetes
mellitus was 2.4 (95% CI: 1.4, 4.2) in females and non-
significant among males (adjusted OR=1.6, 95% CI: 0.8, 3.0).
Additional analyses on the other risk factors did not show such
gender differential effects. However, the gender-specific effects
of smoking and diabetes should be interpreted with caution,
since the interaction terms were not significant (P=0.227 and
P=0.324).
Risk factors for short-term and longer term mortality among
persons with AMI
Table 4 shows the predictors for short-term (57 patients died
within 1 month) and longer term mortality (37 died after
1 month) among persons with AMI. Again, gender is not related
to mortality in univariate analyses. Multivariate analyses
showed higher age and lower BMI to be related to short-term
mortality. After adjustment for other risk factors, male gender is
associated with a 3.2 increased mortality risk on longer term. Intudinal Aging Study, Groningen, The Netherlands, 1993–2001
2 years 5 years 7 years
65 [59, 71] 45 [39, 51] 32 [25, 39]
61 [54, 68] 53 [46, 60] 50 [42, 58]
sons with CHF and 82% of persons with AMI; 7-year follow-up is available for
Table 3
Predictors for mortality in persons with CHF, by Cox proportional hazard models: the Groningen Longitudinal Aging Study, Groningen, The Netherlands, 1993–2001
Univariate Multivariate
OR [95% CI] a ORadj [95% CI]
a
Gender 0=female, 1=male 1.26 [0.93, 1.71] 1.68 [1.19, 2.37] ⁎⁎
Age per 10 years 1.72 [1.39, 2.14] ⁎⁎⁎ 1.96 [1.53, 2.50] ⁎⁎⁎
Partner 0=with, 1=without 1.40 [1.03, 1.91] ⁎
Educational level 0=high, 1= low 1.09 [0.78, 1.53]
Smoking 0=no, 1=yes 1.26 [0.91, 1.75] 1.60 [1.11, 2.31] ⁎
BMI 0=normal, 1=overweight 1.02 [0.73, 1.42]
0=normal, 1=obese 0.84 [0.50, 1.42]
Hypertension 0=no, 1=yes 0.96 [0.68, 1.36]
Diabetes Mellitus 0=no, 1=yes 1.58 [1.05, 2.37] ⁎ 1.98 [1.29, 3.03] ⁎⁎
Chronic conditions per 1 condition 1.03 [0.93, 1.14]
Physical disability per 10 points 1.39 [1.23, 1.57] ⁎⁎⁎ 1.39 [1.20, 1.62] ⁎⁎⁎
Depressive symptoms 0=non case, 1=possible case 1.02 [0.74, 1.42]
Self-rated health 0=high, 1= low 1.46 [1.06, 2.00] ⁎
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longer term mortality. The interaction of gender and diabetes
was borderline significant (P<0.10); diabetes mellitus tended to
be a significant risk factor among females (adjusted OR=7.4,
95% CI: 2.0, 26.6) but not among males (adjusted OR=2.4,
95% CI: 0.9, 6.3).
Additional multivariate analyses, revealed male gender
(OR=1.9, 95% CI: 1.1, 3.1), older age (OR=1.7 per decade,
95% CI: 1.3, 2.3), normal BMI (OR=0.5, 95% CI: 0.3, 0.8 forTable 4
Predictors for mortality in persons with AMI, by Cox proportional hazard models: the
Short-term mortality (within
Univariate M
OR [95% CI] a O
Gender 0=female, 1=male 0.80 [0.47, 1.33]
Age per 10 years 1.78 [1.30, 2.44] ⁎⁎⁎ 1
Partner 0=with, 1=without 1.65 [0.97, 2.80]
Educational level 0=high, 1= low 1.09 [0.64, 1.87]
Smoking 0=no, 1=yes 0.96 [0.57, 1.63]
BMI 0=normal, 1=overweight 0.44 [0.25, 0.76] ⁎⁎ 0
0=normal, 1=obese 0.00 [0.00, ∞] b 0
Hypertension 0=no, 1=yes 1.18 [0.65, 2.16]
Diabetes Mellitus 0=no, 1=yes 1.07 [0.49, 2.37] c
Chronic conditions per 1 condition 1.05 [0.85, 1.30]
Physical disability per 10 points 1.10 [0.77, 1.56]
Depressive symptoms 0=non case, 1=possible case 0.88 [0.44, 1.73]
Self-rated health 0=high, 1= low 1.08 [0.63, 1.87]
a OR=odds ratio. CI=Confidence Interval of odds ratio. ORadj=adjusted odd
b None of the 19 obese AMI patients died within 1 month.
c Interaction term with gender is borderline significant (P<0.10): adjusted O
(95%CI: 0.04, 1.91).
d Interaction term with gender is borderline significant (P<0.10), separate OR
⁎ P<0.05.
⁎⁎ P<0.001.
⁎⁎⁎ P<0.01.overweight; OR=0.4, 95% CI: 0.1, 0.9 for obese), and diabetes
among females (OR=2.8, 95% CI: 1.3, 6.2) as predictors for
total (short- and longer term) mortality in persons with AMI
(data not shown).
Gender-specific mortality rates
In Fig. 1, the survival functions belonging to the multivariate
Cox models show the effects of gender. Male gender isGroningen Longitudinal Aging Study, Groningen, The Netherlands, 1993–2001
1 month) Longer term mortality (after 1 month)
ultivariate Univariate Multivariate
Radj [95% CI]
a OR [95% CI] a ORadj [95% CI]
a
1.65 [0.80, 3.42] 3.19 [1.28, 7.94] ⁎




.51 [0.29, 0.91] ⁎ 0.60 [0.29, 1.23]
.00 [0.00, ∞] b 0.73 [0.27, 2.02]
1.29 [0.61, 2.74]
3.18 [1.50, 6.75] d, ⁎⁎ ♀7.37 [2.04, 26.6]d,⁎⁎




s ratio for variables in the multivariate model.
R for diabetes in females=1.98 (95% CI: 0.78, 5.07) and in males OR=0.26
for males and females are presented for multivariate model.
Fig. 1. Survival curves according to Cox models for patients with CHF and AMI
(adjusted for covariates) by gender: the Groningen Longitudinal Aging Study,
Groningen, The Netherlands, 1993–2001*.
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increased mortality risk in AMI (combining short-term and
longer term mortality).Discussion
One of the most striking findings was that in this sample,
gender was a lurking variable (Joiner, 1981) predicting
mortality for both CHF and AMI. Namely, in neither case
did gender predict mortality in a simple univariate associa-
tion; instead, being male emerged for both conditions as astrong predictor of mortality only in multivariate analyses
taking into account other classic risk factors.
We had postulated two broad strategies for explaining gender
differences in mortality. The first focuses on differences in the
prevalence of risk factors. We have demonstrated that the excess
in mortality risk in males is not due to higher prevalence of other
risk factors (such as smoking). In fact, most risk factors are
more pronounced in females than in males.
The second explanation is that risk factors may have
differential effects for males and females. Our results show
indeed a differential effect of diabetes mellitus, which was a
significant risk factor for longer term mortality among females
with AMI but not among males with AMI. This gender-specific
effect has been described earlier (Crowley et al., 2003; Lee et
al., 2000), and suggested explanations include HDL cholesterol,
estrogens, coagulation, patterns of obesity, or hyperinsulinemia
(Lee et al., 2000) and lower use of effective cardiac medications
in female than male diabetics (Crowley et al., 2003). The
discussion of these theories and others is beyond the scope of
this article; suffice to say that the underlying basis for the gender
differences in risk from diabetes remains, for the most part,
speculative. In addition, data suggest differential effect of
smoking, which may be more relevant in male than in female
patients. Gender differences in sensitivity to smoking has been
reported, showing that males are more affected by smoking (i.e.
higher mortality risks) than females (Marang-van de Mheen et
al., 2001). Thus, risk factors for mortality showed few, albeit
interesting, differences between males and females.
Mortality risk could thus be predicted by six characteristics:
two demographic (high age and male gender), two health
behavioral (low BMI and smoking), and two health parameters
(diabetes mellitus and physical disability). In our elderly
population, higher BMI was related to lower short-term
mortality rates for AMI. These seemingly paradoxical finding
might be seen in contrast with the literature on obesity as a
robust risk factor for mortality (Fontaine et al., 2003). However,
there is some consistency in findings that higher pre-existing
BMI is actually associated with lower risk for mortality (Curtis
et al., 2005; Eisenstein et al., 2005). In older age, a lower BMI
might be a parameter of worse overall health, chronic disease
like cancer, a disturbance of the metabolic system, worse eating
habits or an indicator of physical infirmness. Another possible
explanation relates to selective survivors, indicating that
vulnerable overweighed people have died in earlier life and
that the overweighed people in our older cohort represent a
strong subgroup of overweight people. These indirect explana-
tions are of particular interest since we found lower BMI to be a
predictor of short-term mortality but not on longer term.
There is a large literature concerning mortality associated
with depressive symptoms (Van Melle et al., 2004; Wulsin and
Singal, 2003). Our results do not show any effect of depressive
symptoms on mortality. One of the differences between our
study with those finding an effect of depression is that
depressive symptoms were assessed prior to diagnosis, not
post-morbid. A post-morbid depression may be different from
pre-morbid depression, and effects may differ with time
(Barefoot et al., 1996).
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factors and differential effects of these risk factors are
relevant in examining the gender gap in mortality, but do
not explain the increased mortality risk among male patients
with CHD. Other factors thought to explain this gender gap
include genetics, sex hormones, the pathophysiological origin
and expression of CHF and AMI (Barrett-Connor, 1997).
Furthermore, the gender gap may be related to differences in
referral and therapeutic management (Bouma et al., 1999;
Maynard et al., 1997). However, these differences all favor
male patients and are therefore no help to explain the
increased mortality rates for males. The increased mortality
risk among males with CHD may also relate to overall worse
survival among males in the general population. Females,
who represent the majority of elder persons, have a higher life
expectancy than males but they also experience a longer
disabled life than males. The better survival of females has
often been related to the protective role of estrogens (Isles et
al., 1992). The role of estrogens has been related to
cholesterol and also to the earlier discussed gender differential
effect of diabetes, but may be less important in older (post-
menopausal) women. Clearly, much interesting theories to
explain the gender gap in mortality of CHD patients exist,
and these theories are most definitely not mutually exclusive
and research integrating several theories may be most relevant
in explaining the gender gap.
Study strengths and limitations
In this study, risk factors were assessed prior to the cardiac
diagnosis and this has several advantages, including that all
incident cases in the cohort could be analyzed. This included
also patients who died shortly after diagnosis and patients who
would not give consent to participate in a study once they were
diagnosed. These groups of patients are missed in studies that
rely on data collection after diagnosis.
We demonstrated that the gender gap in mortality is not
accounted for by other classic risk factors. Although we have
included many risk factors, it can be that imbalances in the
occurrence of other (unknown) risk factors related to gender are
important.
Although our study included 472 patients with CHD, the
power of our analyses may be limited since analyses are
performed in subgroups according to the original diagnosis and
included many different risk factors. Nevertheless, our results
gain weight in presenting results for CHF and AMI separately,
since identifying risk factors for specific diseases helps us
understanding the pathways which originate the risks.Conclusions
Mortality is increased among males with CHF or AMI,
compared to female patients. Risk factors for mortality in
newly diagnosed patients are predominantly similar for males
and females, except for diabetes which is a risk factor
among females but not among males. Female cardiacpatients with diabetes mellitus are a particularly high-risk
group in need of targeted treatment strategies and enhanced
lifestyle changes.
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